HIGHLIGHTS
- who: Paolo Sfriso from the Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy have published the research: Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease, in the Journal: (JOURNAL)
- what: The aim of this interventional study is to investigate the efficacy of Canakinumab in 68 patients with AOSD and active joint involvement in terms of the proportion of patients with a clinically significant reduction in disease activity (DAS28 > 1.2) following a treatment period of 12 weeks. The model showed that Canakinumab clearance and volume of distribution . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.